These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 12971860)

  • 1. [Study on drug delivery of the 3H-BCNU polylacties acid released agents on gliosarcoma].
    Zhang YP; Xu XN; Wang JH; Lu G; Liu P; Su TF; Liu HS; Qi JB; Gao B
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2003 Sep; 15(9):568-9. PubMed ID: 12971860
    [No Abstract]   [Full Text] [Related]  

  • 2. Optimizing interstitial delivery of BCNU from controlled release polymers for the treatment of brain tumors.
    Sipos EP; Tyler B; Piantadosi S; Burger PC; Brem H
    Cancer Chemother Pharmacol; 1997; 39(5):383-9. PubMed ID: 9054951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DTI-015 produces cures in T9 gliosarcoma.
    Pietronigro D; Drnovsky F; Cravioto H; Ransohoff J
    Neoplasia; 2003; 5(1):17-22. PubMed ID: 12659666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. O6-benzylguanine potentiates the antitumor effect of locally delivered carmustine against an intracranial rat glioma.
    Rhines LD; Sampath P; Dolan ME; Tyler BM; Brem H; Weingart J
    Cancer Res; 2000 Nov; 60(22):6307-10. PubMed ID: 11103789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interstitial chemotherapy of experimental brain tumors: comparison of intratumoral injection versus polymeric controlled release.
    Buahin KG; Brem H
    J Neurooncol; 1995 Nov; 26(2):103-10. PubMed ID: 8787852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resorbable polymer microchips releasing BCNU inhibit tumor growth in the rat 9L flank model.
    Kim GY; Tyler BM; Tupper MM; Karp JM; Langer RS; Brem H; Cima MJ
    J Control Release; 2007 Nov; 123(2):172-8. PubMed ID: 17884232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local delivery of minocycline and systemic BCNU have synergistic activity in the treatment of intracranial glioma.
    Frazier JL; Wang PP; Case D; Tyler BM; Pradilla G; Weingart JD; Brem H
    J Neurooncol; 2003 Sep; 64(3):203-9. PubMed ID: 14558595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of the stability of BCNU using self-emulsifying drug delivery systems (SEDDS) and in vitro antitumor activity of self-emulsified BCNU-loaded PLGA wafer.
    Chae GS; Lee JS; Kim SH; Seo KS; Kim MS; Lee HB; Khang G
    Int J Pharm; 2005 Sep; 301(1-2):6-14. PubMed ID: 16024190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local immunotherapy with interleukin-2 delivered from biodegradable polymer microspheres combined with interstitial chemotherapy: a novel treatment for experimental malignant glioma.
    Rhines LD; Sampath P; DiMeco F; Lawson HC; Tyler BM; Hanes J; Olivi A; Brem H
    Neurosurgery; 2003 Apr; 52(4):872-9; discussion 879-80. PubMed ID: 12657184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intralesionally implanted cisplatin plus systemic carmustine for the treatment of brain tumor in rats.
    Kong Q; Kleinschmidt-DeMasters BK; Lillehei KO
    J Surg Oncol; 1998 Oct; 69(2):76-82. PubMed ID: 9808509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of in vitro and in vivo antitumor activity of BCNU-loaded PLGA wafer against 9L gliosarcoma.
    Lee JS; An TK; Chae GS; Jeong JK; Cho SH; Lee HB; Khang G
    Eur J Pharm Biopharm; 2005 Jan; 59(1):169-75. PubMed ID: 15567315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gliadel wafer in initial surgery for malignant glioma: long-term follow-up of a multicenter controlled trial.
    Westphal M; Ram Z; Riddle V; Hilt D; Bortey E;
    Acta Neurochir (Wien); 2006 Mar; 148(3):269-75; discussion 275. PubMed ID: 16482400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of BCNU polymer wafers (Gliadel) in the treatment of malignant glioma.
    Nagpal S
    Neurosurg Clin N Am; 2012 Apr; 23(2):289-95, ix. PubMed ID: 22440872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BCNU-loaded PEG-PLLA ultrafine fibers and their in vitro antitumor activity against Glioma C6 cells.
    Xu X; Chen X; Xu X; Lu T; Wang X; Yang L; Jing X
    J Control Release; 2006 Sep; 114(3):307-16. PubMed ID: 16891029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose escalation of carmustine in surgically implanted polymers in patients with recurrent malignant glioma: a New Approaches to Brain Tumor Therapy CNS Consortium trial.
    Olivi A; Grossman SA; Tatter S; Barker F; Judy K; Olsen J; Bruce J; Hilt D; Fisher J; Piantadosi S;
    J Clin Oncol; 2003 May; 21(9):1845-9. PubMed ID: 12721262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic cytotoxicity of the ribonucleotide reductase inhibitor didox (3,4-dihydroxy-benzohydroxamic acid) and the alkylating agent carmustine (BCNU) in 9L rat gliosarcoma cells and DAOY human medulloblastoma cells.
    Horvath Z; Höchtl T; Bauer W; Fritzer-Szekeres M; Elford HL; Szekeres T; Tihan T
    Cancer Chemother Pharmacol; 2004 Aug; 54(2):139-45. PubMed ID: 15133626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local delivery of doxorubicin for the treatment of malignant brain tumors in rats.
    Lesniak MS; Upadhyay U; Goodwin R; Tyler B; Brem H
    Anticancer Res; 2005; 25(6B):3825-31. PubMed ID: 16312042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Risk Factors for Adverse Events after Implantation of BCNU Wafers in High-grade Gliomas].
    Yoshida M; Yamaguchi S; Ishi Y; Endo S; Motegi H; Kobayashi H; Asaoka K; Kamoshima Y; Terasaka S; Houkin K
    No Shinkei Geka; 2015 Jul; 43(7):603-10. PubMed ID: 26136324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The delivery of BCNU to brain tumors.
    Wang CC; Li J; Teo CS; Lee T
    J Control Release; 1999 Aug; 61(1-2):21-41. PubMed ID: 10469900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of sister chromatid exchange induction in intracerebral brain tumors as a method for evaluation of therapeutic drug combinations.
    Bodell WJ
    Anticancer Res; 2000; 20(5A):3099-103. PubMed ID: 11062728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.